FindTrial
Sign In

AI-Based Precision Phenotyping and Prognostic Modeling in HFpEF

AI-Based Precision Phenotyping and Prognostic Modeling in HFpEF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111082
Enrollment
Unknown
Registered
2025-10-24
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Exposure group (hypothyroidism):None
Non-exposed group (Normal thyroid function level):None

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Adult patients (>= 18 years) who have provided written informed consent and present with symptoms or signs of heart failure, with a clinical diagnosis of heart failure.

Exclusion criteria

Exclusion criteria: 1.Patients who subsequently withdraw their informed consent.

Design outcomes

Primary

MeasureTime frame
Composite endpoint of heart failure rehospitalization or all-cause mortality: Unplanned rehospitalization for heart failure is defined as readmission occurring =1 week after discharge due to worsening;—

Countries

China

Contacts

Public ContactXinwei Hua

Peking University Third Hospital

xhua@pku.edu.cn+86 10 8226 2626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026